Company: HCTI
Filing Date: 2025-10-02
Form Type: PRE 14C
Source: 0001213900-25-095494
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-02
Form: PRE 14C
Chunk 1
---
 Majority Stockholder approved and authorized
the issuance of 1,388,041 shares of the Company’s restricted common stock (the “Acquisition Shares”) to Niyama
Healthcare, Inc., a Delaware corporation and provider of Mental Health and Hospital Information Systems technology, across India, South
East Asia, and Europe (the “Seller”), pursuant to an Asst Transfer Agreement dated June 16, 2025 and amended on August
28, 2025, as partial consideration for the acquisition (the “Acquisition”) by the the Company of (i) all of
the Seller’s assets related to its cloud and technology domain business and (ii) 100% of the equity of interest in Ezovion
Solutions Private Limited, a Hospital Information Systems SaaS Provider in Chennai, India. The other consideration paid or payable
by the Company includes: (1) $1.5 million in cash, of which $1.2 million was due at the closing of the Acquisition and $300,000 to be
paid at the later of the satisfaction of certain withholding requirements or within 120 days of the closing and (2) up to $1.2 million
in earn-out payments contingent on first-year financial performance targets to be agreed upon within 90 days of the closing of the Acquisition.

As described more fully in this Information Statement,
stockholder approval is required by Nasdaq Listing Rule 5635(a)(2), prior to the issuance of the Acquisition Shares. The Majority
Stockholder approved the issuance of the Acquisition Shares by written consent on September 19, 2025. Our board of directors is not soliciting
your consent or your proxy in connection with this action and neither consents nor proxies are being requested from stockholders.

Pursuant to Rule 14c-2(b) of the Exchange
Act, the action taken by written consent of the Majority Stockholder will not become effective until the date that is twenty (20) calendar
days after this Information Statement is first mailed or otherwise delivered to holders of our common stock as of the Record Date.

By Order of the Board of Directors

| /s/             
 David Ayanoglou |

David Ayanoglou

Chief Financial Officer

October [*], 2025

<div align='center'>1

HEALTHCARE TRIANGLE, INC.

7901 Stoneridge Drive, Suite 220

Pleasanton, California 94588

INFORMATION STATEMENT

October [*], 2025

NOT